Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -65.31% is 43% above its 5-year average of -115.41%, near the high end of its 5-year range (-41784.92%–21.51%).
18.46% above its 12-month average of -80.10%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -148.89%.
NET PROFIT MARGIN
-65.31%
NET PROFIT MARGIN AVG TTM
-80.10%
NET PROFIT MARGIN AVG 3Y
-184.66%
NET PROFIT MARGIN AVG 5Y
-115.41%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+18.46%
CURRENT VS 3Y AVG
+64.63%
CURRENT VS 5Y AVG
+43.41%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-25019.23%
vs the sector median at left
QT Imaging Holdings, Inc.
Market Cap
$36.28M
Net Profit Margin
-65.31%
TTM Avg
-80.10%
3Y Avg
-184.66%
5Y Avg
-115.41%
Market Cap
$36.42M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-479.12%
Market Cap
$35.69M
Net Profit Margin
-40.49%
TTM Avg
-211.76%
3Y Avg
-338.86%
5Y Avg
-222.41%
Market Cap
$36.99M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-322.60%
Market Cap
$35.56M
Net Profit Margin
-65.29%
TTM Avg
-26.68%
3Y Avg
-11.11%
5Y Avg
-8.71%
Market Cap
$35.50M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$36.91M
Net Profit Margin
8.38%
TTM Avg
3.43%
3Y Avg
-19.55%
5Y Avg
-29.01%
Market Cap
$37.57M
Net Profit Margin
0.00%
TTM Avg
-27258.72%
3Y Avg
-52085.61%
5Y Avg
-35139.97%
Market Cap
$34.48M
Net Profit Margin
426.93%
TTM Avg
106.45%
3Y Avg
-19.31%
5Y Avg
-30.13%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| QT Imaging Holdings, Inc. (QTI) | $36.28M | -65.31% | -80.10% | -184.66% | -115.41% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.42M | 0.00% | 0.00% | 0.00% | -479.12% |
| EUDA Health Holdings Limited (EUDA)vs › | $35.69M | -40.49% | -211.76% | -338.86% | -222.41% |
| Edesa Biotech, Inc. (EDSA)vs › | $36.99M | 0.00% | 0.00% | 0.00% | -322.60% |
| DocGo Inc. (DCGO)vs › | $35.56M | -65.29% | -26.68% | -11.11% | -8.71% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| Nephros, Inc. (NEPH)vs › | $36.91M | 8.38% | 3.43% | -19.55% | -29.01% |
| Incannex Healthcare Limited (IXHL)vs › | $37.57M | 0.00% | -27258.72% | -52085.61% | -35139.97% |
| Elutia Inc (ELUT)vs › | $34.48M | 426.93% | 106.45% | -19.31% | -30.13% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.42M | 0.00% | 0.00% | 0.00% | -1673.30% |
Operating Margin
-17.4%
Net Profit Margin
-65.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -148.89% |
| 2026-03-31 | -16.76% |
| 2025-12-31 | -16.77% |
| 2025-09-30 | -108.71% |
| 2025-06-30 | -109.35% |
| 2025-03-31 | -398.00% |
| 2024-12-31 | 21.51% |
| 2024-09-30 | -378.62% |
| 2024-06-30 | -375.39% |
| 2024-03-31 | -315.57% |
| 2023-12-31 | -30499.92% |
| 2023-09-30 | -5580.32% |
| 2023-06-30 | -41784.92% |
| 2023-03-31 | -24893.54% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-02-28 | 0.00% |